Global Total Hip Replacement
Global Total Hip Replacement

Total Hip Replacement Comprehensive Study by Application (Age Below 45, Age 45-65, Age Above 65), Materials Use By Doctors (Components of a Hip Replacement, Implant Materials, Cemented and Cementless, Metal-On-Plastic Implants, Ceramic-On-Ceramic Implants), Approach Type (Anterior Approach to the Hip, Posterior Approaches to the Hip), Treat Conditions (Osteoarthritis of the Hip, Rheumatoid Arthritis, Traumatic Arthritis, Ankylosing Spondylitis, Avascular Necrosis, Certain Hip Fractures, Benign and Malignant Tumors) Players and Region - Global Market Outlook to 2024

Total Hip Replacement Market Segmented into XX Submarkets. | Forecast Years: 2019- 2024  

Oct 2019 Edition 212 Pages 161 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Global Total Hip Replacement Market Overview:
The total hip replacement procedure is to replicate the action of the natural joint. This is done in four parts, a socket, liner, ball, and stem. In this, the cup is made of metal and fits into the natural hip socket. The liner is made up of medical grade polyethylene. In coming years Artificial Intelligence helps orthopedic surgeons to predict which patients will do well after joint replacement procedures and which less benefited are. Some of the key players profiled in the study are Johnson & Johnson (United States), Stryker (United States), Zimmer Biomet (United States), Smith & Nephew (United Kingdom), Wright Medical (United States), ConforMIS (United States), Corin (United Kingdom) and Maxx Orthopedics Inc. (United States).

On the basis of geography, the market of Total Hip Replacement has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Materials Use By Doctors, the sub-segment i.e. Components of a Hip Replacement will boost the Total Hip Replacement market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Approach Type, the sub-segment i.e. Anterior Approach to the Hip will boost the Total Hip Replacement market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Treat Conditions, the sub-segment i.e. Osteoarthritis of the Hip will boost the Total Hip Replacement market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Increase in Chronic Pain and Impairment of Daily Function of Patients
  • Rising Severe Arthritic Conditions, Especially Osteoarthritis

Market Trend
  • Increasing Number of Young and Active Patients Undergoing Hip Arthroplasty
  • Surface Replacement or Short-Stemmed Femoral Shaft Prostheses


Opportunities
  • High opportunity in United States due to rising number of individuals in the United States opt for elective joint replacements to maintain active lifestyles

Challenges
  • Risks Generated After This Industry Includes Blood Clots, Infection
  • Create Metal-On-Metal Complications


Major Market Developments:

In Mar 2019, Corin announced the acquisition of OMNI, this agreement accelerates the Corinís growth strategy and provides a greater foothold in the United States.
In Aug 2018, Conforming introduced the first two Conformis Hip System implants. The company designed the first ever 3D designed primary total hip replacement system. Through this step, the company expects to lead USD 7 billion hip replacement market by providing surgeons with game-changing operative solutions.

Target Audience:
Venture Capitalists and Private Equity Firms, New Entrants/Investors, Analysts and Strategic Business Planners, Government Regulatory and Research Organizations and End-Use Industries

Major Objectives Focused through this Study
• To define, describe, and forecast the Global Total Hip Replacement market on the basis of product [] , application [Age Below 45, Age 45-65 and Age Above 65], key regions and end user
• To provide in-depth information regarding major influencing factors affecting the growth of the market (trends, drivers, restraints, opportunities, and industry-centric and regional challenges)
• To strategically analyse the micro-markets and important business segments with respect to individual growth drivers , market trends and potential, and historical contributions to the total market
• Identifying the opportunities in the market for key stakeholders and detailing the competitive landscape for market leaders
• To provide market size for various segments of the Total Hip Replacement market with respect to major geographies, namely, South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico)
• To strategically profile the key players and analyzing their market shares and core competencies in the Total Hip Replacement industry
• To track key developments such as product launches, expansions, agreements, partnerships, mergers & acquisitions, and R&D activities that are key factors in shaping the market

Available Customization:
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**. Additionally, the Players which are also part of the research are .
** Confirmation on availability of data would be informed prior purchase

While framing the research framework, major and emerging players operating in the Total Hip Replacement market in various regions have been profiled, and their offerings, geographic footprints, and distribution/sales channels have been analysed through in-depth discussions. Top-down and bottom-up approaches have been used to determine the overall market size. Sizes of the other individual markets have been estimated using the percentage splits obtained through secondary sources such as Hoovers, Bloomberg BusinessWeek, and Dow Jones (Factiva), along with primary respondents. The complete methodology includes the study of the annual and financial reports of the key market players and extensive interviews with industry experts such as CEOs, VPs, directors, and marketing executives for key insights (both qualitative and quantitative) related to the market.
Report Objectives / Segmentation Covered
By Application
  • Age Below 45
  • Age 45-65
  • Age Above 65
By Materials Use By Doctors
  • Components of a Hip Replacement
  • Implant Materials
  • Cemented and Cementless
  • Metal-On-Plastic Implants
  • Ceramic-On-Ceramic Implants

By Approach Type
  • Anterior Approach to the Hip
  • Posterior Approaches to the Hip

By Treat Conditions
  • Osteoarthritis of the Hip
  • Rheumatoid Arthritis
  • Traumatic Arthritis
  • Ankylosing Spondylitis
  • Avascular Necrosis
  • Certain Hip Fractures
  • Benign and Malignant Tumors

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increase in Chronic Pain and Impairment of Daily Function of Patients
      • 3.2.2. Rising Severe Arthritic Conditions, Especially Osteoarthritis
    • 3.3. Market Challenges
      • 3.3.1. Risks Generated After This Industry Includes Blood Clots, Infection
      • 3.3.2. Create Metal-On-Metal Complications
    • 3.4. Market Trends
      • 3.4.1. Increasing Number of Young and Active Patients Undergoing Hip Arthroplasty
      • 3.4.2. Surface Replacement or Short-Stemmed Femoral Shaft Prostheses
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Total Hip Replacement, by Application, Materials Use By Doctors, Approach Type, Treat Conditions and Region (value) (2013-2018)
    • 5.1. Introduction
    • 5.2. Global Total Hip Replacement (Value)
      • 5.2.1. Global Total Hip Replacement by: Application (Value)
        • 5.2.1.1. Age Below 45
        • 5.2.1.2. Age 45-65
        • 5.2.1.3. Age Above 65
      • 5.2.2. Global Total Hip Replacement by: Materials Use By Doctors (Value)
        • 5.2.2.1. Components of a Hip Replacement
        • 5.2.2.2. Implant Materials
        • 5.2.2.3. Cemented and Cementless
        • 5.2.2.4. Metal-On-Plastic Implants
        • 5.2.2.5. Ceramic-On-Ceramic Implants
      • 5.2.3. Global Total Hip Replacement by: Approach Type (Value)
        • 5.2.3.1. Anterior Approach to the Hip
        • 5.2.3.2. Posterior Approaches to the Hip
      • 5.2.4. Global Total Hip Replacement by: Treat Conditions (Value)
        • 5.2.4.1. Osteoarthritis of the Hip
        • 5.2.4.2. Rheumatoid Arthritis
        • 5.2.4.3. Traumatic Arthritis
        • 5.2.4.4. Ankylosing Spondylitis
        • 5.2.4.5. Avascular Necrosis
        • 5.2.4.6. Certain Hip Fractures
        • 5.2.4.7. Benign and Malignant Tumors
      • 5.2.5. Global Total Hip Replacement Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Total Hip Replacement: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2018)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Johnson & Johnson (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Stryker (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Zimmer Biomet (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Smith & Nephew (United Kingdom)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Wright Medical (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. ConforMIS (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Corin (United Kingdom)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Maxx Orthopedics Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
  • 7. Global Total Hip Replacement Sale, by Application, Materials Use By Doctors, Approach Type, Treat Conditions and Region (value) (2019-2024)
    • 7.1. Introduction
    • 7.2. Global Total Hip Replacement (Value)
      • 7.2.1. Global Total Hip Replacement by: Application (Value)
        • 7.2.1.1. Age Below 45
        • 7.2.1.2. Age 45-65
        • 7.2.1.3. Age Above 65
      • 7.2.2. Global Total Hip Replacement by: Materials Use By Doctors (Value)
        • 7.2.2.1. Components of a Hip Replacement
        • 7.2.2.2. Implant Materials
        • 7.2.2.3. Cemented and Cementless
        • 7.2.2.4. Metal-On-Plastic Implants
        • 7.2.2.5. Ceramic-On-Ceramic Implants
      • 7.2.3. Global Total Hip Replacement by: Approach Type (Value)
        • 7.2.3.1. Anterior Approach to the Hip
        • 7.2.3.2. Posterior Approaches to the Hip
      • 7.2.4. Global Total Hip Replacement by: Treat Conditions (Value)
        • 7.2.4.1. Osteoarthritis of the Hip
        • 7.2.4.2. Rheumatoid Arthritis
        • 7.2.4.3. Traumatic Arthritis
        • 7.2.4.4. Ankylosing Spondylitis
        • 7.2.4.5. Avascular Necrosis
        • 7.2.4.6. Certain Hip Fractures
        • 7.2.4.7. Benign and Malignant Tumors
      • 7.2.5. Global Total Hip Replacement Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Total Hip Replacement: by Application(USD Million)
  • Table 2. Total Hip Replacement Age Below 45 , by Region USD Million (2013-2018)
  • Table 3. Total Hip Replacement Age 45-65 , by Region USD Million (2013-2018)
  • Table 4. Total Hip Replacement Age Above 65 , by Region USD Million (2013-2018)
  • Table 5. Total Hip Replacement: by Materials Use By Doctors(USD Million)
  • Table 6. Total Hip Replacement Components of a Hip Replacement , by Region USD Million (2013-2018)
  • Table 7. Total Hip Replacement Implant Materials , by Region USD Million (2013-2018)
  • Table 8. Total Hip Replacement Cemented and Cementless , by Region USD Million (2013-2018)
  • Table 9. Total Hip Replacement Metal-On-Plastic Implants , by Region USD Million (2013-2018)
  • Table 10. Total Hip Replacement Ceramic-On-Ceramic Implants , by Region USD Million (2013-2018)
  • Table 11. Total Hip Replacement: by Approach Type(USD Million)
  • Table 12. Total Hip Replacement Anterior Approach to the Hip , by Region USD Million (2013-2018)
  • Table 13. Total Hip Replacement Posterior Approaches to the Hip , by Region USD Million (2013-2018)
  • Table 14. Total Hip Replacement: by Treat Conditions(USD Million)
  • Table 15. Total Hip Replacement Osteoarthritis of the Hip , by Region USD Million (2013-2018)
  • Table 16. Total Hip Replacement Rheumatoid Arthritis , by Region USD Million (2013-2018)
  • Table 17. Total Hip Replacement Traumatic Arthritis , by Region USD Million (2013-2018)
  • Table 18. Total Hip Replacement Ankylosing Spondylitis , by Region USD Million (2013-2018)
  • Table 19. Total Hip Replacement Avascular Necrosis , by Region USD Million (2013-2018)
  • Table 20. Total Hip Replacement Certain Hip Fractures , by Region USD Million (2013-2018)
  • Table 21. Total Hip Replacement Benign and Malignant Tumors , by Region USD Million (2013-2018)
  • Table 22. South America Total Hip Replacement, by Country USD Million (2013-2018)
  • Table 23. South America Total Hip Replacement, by Application USD Million (2013-2018)
  • Table 24. South America Total Hip Replacement, by Materials Use By Doctors USD Million (2013-2018)
  • Table 25. South America Total Hip Replacement, by Approach Type USD Million (2013-2018)
  • Table 26. South America Total Hip Replacement, by Treat Conditions USD Million (2013-2018)
  • Table 27. Brazil Total Hip Replacement, by Application USD Million (2013-2018)
  • Table 28. Brazil Total Hip Replacement, by Materials Use By Doctors USD Million (2013-2018)
  • Table 29. Brazil Total Hip Replacement, by Approach Type USD Million (2013-2018)
  • Table 30. Brazil Total Hip Replacement, by Treat Conditions USD Million (2013-2018)
  • Table 31. Argentina Total Hip Replacement, by Application USD Million (2013-2018)
  • Table 32. Argentina Total Hip Replacement, by Materials Use By Doctors USD Million (2013-2018)
  • Table 33. Argentina Total Hip Replacement, by Approach Type USD Million (2013-2018)
  • Table 34. Argentina Total Hip Replacement, by Treat Conditions USD Million (2013-2018)
  • Table 35. Rest of South America Total Hip Replacement, by Application USD Million (2013-2018)
  • Table 36. Rest of South America Total Hip Replacement, by Materials Use By Doctors USD Million (2013-2018)
  • Table 37. Rest of South America Total Hip Replacement, by Approach Type USD Million (2013-2018)
  • Table 38. Rest of South America Total Hip Replacement, by Treat Conditions USD Million (2013-2018)
  • Table 39. Asia Pacific Total Hip Replacement, by Country USD Million (2013-2018)
  • Table 40. Asia Pacific Total Hip Replacement, by Application USD Million (2013-2018)
  • Table 41. Asia Pacific Total Hip Replacement, by Materials Use By Doctors USD Million (2013-2018)
  • Table 42. Asia Pacific Total Hip Replacement, by Approach Type USD Million (2013-2018)
  • Table 43. Asia Pacific Total Hip Replacement, by Treat Conditions USD Million (2013-2018)
  • Table 44. China Total Hip Replacement, by Application USD Million (2013-2018)
  • Table 45. China Total Hip Replacement, by Materials Use By Doctors USD Million (2013-2018)
  • Table 46. China Total Hip Replacement, by Approach Type USD Million (2013-2018)
  • Table 47. China Total Hip Replacement, by Treat Conditions USD Million (2013-2018)
  • Table 48. Japan Total Hip Replacement, by Application USD Million (2013-2018)
  • Table 49. Japan Total Hip Replacement, by Materials Use By Doctors USD Million (2013-2018)
  • Table 50. Japan Total Hip Replacement, by Approach Type USD Million (2013-2018)
  • Table 51. Japan Total Hip Replacement, by Treat Conditions USD Million (2013-2018)
  • Table 52. India Total Hip Replacement, by Application USD Million (2013-2018)
  • Table 53. India Total Hip Replacement, by Materials Use By Doctors USD Million (2013-2018)
  • Table 54. India Total Hip Replacement, by Approach Type USD Million (2013-2018)
  • Table 55. India Total Hip Replacement, by Treat Conditions USD Million (2013-2018)
  • Table 56. South Korea Total Hip Replacement, by Application USD Million (2013-2018)
  • Table 57. South Korea Total Hip Replacement, by Materials Use By Doctors USD Million (2013-2018)
  • Table 58. South Korea Total Hip Replacement, by Approach Type USD Million (2013-2018)
  • Table 59. South Korea Total Hip Replacement, by Treat Conditions USD Million (2013-2018)
  • Table 60. Taiwan Total Hip Replacement, by Application USD Million (2013-2018)
  • Table 61. Taiwan Total Hip Replacement, by Materials Use By Doctors USD Million (2013-2018)
  • Table 62. Taiwan Total Hip Replacement, by Approach Type USD Million (2013-2018)
  • Table 63. Taiwan Total Hip Replacement, by Treat Conditions USD Million (2013-2018)
  • Table 64. Australia Total Hip Replacement, by Application USD Million (2013-2018)
  • Table 65. Australia Total Hip Replacement, by Materials Use By Doctors USD Million (2013-2018)
  • Table 66. Australia Total Hip Replacement, by Approach Type USD Million (2013-2018)
  • Table 67. Australia Total Hip Replacement, by Treat Conditions USD Million (2013-2018)
  • Table 68. Rest of Asia-Pacific Total Hip Replacement, by Application USD Million (2013-2018)
  • Table 69. Rest of Asia-Pacific Total Hip Replacement, by Materials Use By Doctors USD Million (2013-2018)
  • Table 70. Rest of Asia-Pacific Total Hip Replacement, by Approach Type USD Million (2013-2018)
  • Table 71. Rest of Asia-Pacific Total Hip Replacement, by Treat Conditions USD Million (2013-2018)
  • Table 72. Europe Total Hip Replacement, by Country USD Million (2013-2018)
  • Table 73. Europe Total Hip Replacement, by Application USD Million (2013-2018)
  • Table 74. Europe Total Hip Replacement, by Materials Use By Doctors USD Million (2013-2018)
  • Table 75. Europe Total Hip Replacement, by Approach Type USD Million (2013-2018)
  • Table 76. Europe Total Hip Replacement, by Treat Conditions USD Million (2013-2018)
  • Table 77. Germany Total Hip Replacement, by Application USD Million (2013-2018)
  • Table 78. Germany Total Hip Replacement, by Materials Use By Doctors USD Million (2013-2018)
  • Table 79. Germany Total Hip Replacement, by Approach Type USD Million (2013-2018)
  • Table 80. Germany Total Hip Replacement, by Treat Conditions USD Million (2013-2018)
  • Table 81. France Total Hip Replacement, by Application USD Million (2013-2018)
  • Table 82. France Total Hip Replacement, by Materials Use By Doctors USD Million (2013-2018)
  • Table 83. France Total Hip Replacement, by Approach Type USD Million (2013-2018)
  • Table 84. France Total Hip Replacement, by Treat Conditions USD Million (2013-2018)
  • Table 85. Italy Total Hip Replacement, by Application USD Million (2013-2018)
  • Table 86. Italy Total Hip Replacement, by Materials Use By Doctors USD Million (2013-2018)
  • Table 87. Italy Total Hip Replacement, by Approach Type USD Million (2013-2018)
  • Table 88. Italy Total Hip Replacement, by Treat Conditions USD Million (2013-2018)
  • Table 89. United Kingdom Total Hip Replacement, by Application USD Million (2013-2018)
  • Table 90. United Kingdom Total Hip Replacement, by Materials Use By Doctors USD Million (2013-2018)
  • Table 91. United Kingdom Total Hip Replacement, by Approach Type USD Million (2013-2018)
  • Table 92. United Kingdom Total Hip Replacement, by Treat Conditions USD Million (2013-2018)
  • Table 93. Netherlands Total Hip Replacement, by Application USD Million (2013-2018)
  • Table 94. Netherlands Total Hip Replacement, by Materials Use By Doctors USD Million (2013-2018)
  • Table 95. Netherlands Total Hip Replacement, by Approach Type USD Million (2013-2018)
  • Table 96. Netherlands Total Hip Replacement, by Treat Conditions USD Million (2013-2018)
  • Table 97. Rest of Europe Total Hip Replacement, by Application USD Million (2013-2018)
  • Table 98. Rest of Europe Total Hip Replacement, by Materials Use By Doctors USD Million (2013-2018)
  • Table 99. Rest of Europe Total Hip Replacement, by Approach Type USD Million (2013-2018)
  • Table 100. Rest of Europe Total Hip Replacement, by Treat Conditions USD Million (2013-2018)
  • Table 101. MEA Total Hip Replacement, by Country USD Million (2013-2018)
  • Table 102. MEA Total Hip Replacement, by Application USD Million (2013-2018)
  • Table 103. MEA Total Hip Replacement, by Materials Use By Doctors USD Million (2013-2018)
  • Table 104. MEA Total Hip Replacement, by Approach Type USD Million (2013-2018)
  • Table 105. MEA Total Hip Replacement, by Treat Conditions USD Million (2013-2018)
  • Table 106. Middle East Total Hip Replacement, by Application USD Million (2013-2018)
  • Table 107. Middle East Total Hip Replacement, by Materials Use By Doctors USD Million (2013-2018)
  • Table 108. Middle East Total Hip Replacement, by Approach Type USD Million (2013-2018)
  • Table 109. Middle East Total Hip Replacement, by Treat Conditions USD Million (2013-2018)
  • Table 110. Africa Total Hip Replacement, by Application USD Million (2013-2018)
  • Table 111. Africa Total Hip Replacement, by Materials Use By Doctors USD Million (2013-2018)
  • Table 112. Africa Total Hip Replacement, by Approach Type USD Million (2013-2018)
  • Table 113. Africa Total Hip Replacement, by Treat Conditions USD Million (2013-2018)
  • Table 114. North America Total Hip Replacement, by Country USD Million (2013-2018)
  • Table 115. North America Total Hip Replacement, by Application USD Million (2013-2018)
  • Table 116. North America Total Hip Replacement, by Materials Use By Doctors USD Million (2013-2018)
  • Table 117. North America Total Hip Replacement, by Approach Type USD Million (2013-2018)
  • Table 118. North America Total Hip Replacement, by Treat Conditions USD Million (2013-2018)
  • Table 119. United States Total Hip Replacement, by Application USD Million (2013-2018)
  • Table 120. United States Total Hip Replacement, by Materials Use By Doctors USD Million (2013-2018)
  • Table 121. United States Total Hip Replacement, by Approach Type USD Million (2013-2018)
  • Table 122. United States Total Hip Replacement, by Treat Conditions USD Million (2013-2018)
  • Table 123. Canada Total Hip Replacement, by Application USD Million (2013-2018)
  • Table 124. Canada Total Hip Replacement, by Materials Use By Doctors USD Million (2013-2018)
  • Table 125. Canada Total Hip Replacement, by Approach Type USD Million (2013-2018)
  • Table 126. Canada Total Hip Replacement, by Treat Conditions USD Million (2013-2018)
  • Table 127. Mexico Total Hip Replacement, by Application USD Million (2013-2018)
  • Table 128. Mexico Total Hip Replacement, by Materials Use By Doctors USD Million (2013-2018)
  • Table 129. Mexico Total Hip Replacement, by Approach Type USD Million (2013-2018)
  • Table 130. Mexico Total Hip Replacement, by Treat Conditions USD Million (2013-2018)
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Total Hip Replacement: by Application(USD Million)
  • Table 140. Total Hip Replacement Age Below 45 , by Region USD Million (2019-2024)
  • Table 141. Total Hip Replacement Age 45-65 , by Region USD Million (2019-2024)
  • Table 142. Total Hip Replacement Age Above 65 , by Region USD Million (2019-2024)
  • Table 143. Total Hip Replacement: by Materials Use By Doctors(USD Million)
  • Table 144. Total Hip Replacement Components of a Hip Replacement , by Region USD Million (2019-2024)
  • Table 145. Total Hip Replacement Implant Materials , by Region USD Million (2019-2024)
  • Table 146. Total Hip Replacement Cemented and Cementless , by Region USD Million (2019-2024)
  • Table 147. Total Hip Replacement Metal-On-Plastic Implants , by Region USD Million (2019-2024)
  • Table 148. Total Hip Replacement Ceramic-On-Ceramic Implants , by Region USD Million (2019-2024)
  • Table 149. Total Hip Replacement: by Approach Type(USD Million)
  • Table 150. Total Hip Replacement Anterior Approach to the Hip , by Region USD Million (2019-2024)
  • Table 151. Total Hip Replacement Posterior Approaches to the Hip , by Region USD Million (2019-2024)
  • Table 152. Total Hip Replacement: by Treat Conditions(USD Million)
  • Table 153. Total Hip Replacement Osteoarthritis of the Hip , by Region USD Million (2019-2024)
  • Table 154. Total Hip Replacement Rheumatoid Arthritis , by Region USD Million (2019-2024)
  • Table 155. Total Hip Replacement Traumatic Arthritis , by Region USD Million (2019-2024)
  • Table 156. Total Hip Replacement Ankylosing Spondylitis , by Region USD Million (2019-2024)
  • Table 157. Total Hip Replacement Avascular Necrosis , by Region USD Million (2019-2024)
  • Table 158. Total Hip Replacement Certain Hip Fractures , by Region USD Million (2019-2024)
  • Table 159. Total Hip Replacement Benign and Malignant Tumors , by Region USD Million (2019-2024)
  • Table 160. South America Total Hip Replacement, by Country USD Million (2019-2024)
  • Table 161. South America Total Hip Replacement, by Application USD Million (2019-2024)
  • Table 162. South America Total Hip Replacement, by Materials Use By Doctors USD Million (2019-2024)
  • Table 163. South America Total Hip Replacement, by Approach Type USD Million (2019-2024)
  • Table 164. South America Total Hip Replacement, by Treat Conditions USD Million (2019-2024)
  • Table 165. Brazil Total Hip Replacement, by Application USD Million (2019-2024)
  • Table 166. Brazil Total Hip Replacement, by Materials Use By Doctors USD Million (2019-2024)
  • Table 167. Brazil Total Hip Replacement, by Approach Type USD Million (2019-2024)
  • Table 168. Brazil Total Hip Replacement, by Treat Conditions USD Million (2019-2024)
  • Table 169. Argentina Total Hip Replacement, by Application USD Million (2019-2024)
  • Table 170. Argentina Total Hip Replacement, by Materials Use By Doctors USD Million (2019-2024)
  • Table 171. Argentina Total Hip Replacement, by Approach Type USD Million (2019-2024)
  • Table 172. Argentina Total Hip Replacement, by Treat Conditions USD Million (2019-2024)
  • Table 173. Rest of South America Total Hip Replacement, by Application USD Million (2019-2024)
  • Table 174. Rest of South America Total Hip Replacement, by Materials Use By Doctors USD Million (2019-2024)
  • Table 175. Rest of South America Total Hip Replacement, by Approach Type USD Million (2019-2024)
  • Table 176. Rest of South America Total Hip Replacement, by Treat Conditions USD Million (2019-2024)
  • Table 177. Asia Pacific Total Hip Replacement, by Country USD Million (2019-2024)
  • Table 178. Asia Pacific Total Hip Replacement, by Application USD Million (2019-2024)
  • Table 179. Asia Pacific Total Hip Replacement, by Materials Use By Doctors USD Million (2019-2024)
  • Table 180. Asia Pacific Total Hip Replacement, by Approach Type USD Million (2019-2024)
  • Table 181. Asia Pacific Total Hip Replacement, by Treat Conditions USD Million (2019-2024)
  • Table 182. China Total Hip Replacement, by Application USD Million (2019-2024)
  • Table 183. China Total Hip Replacement, by Materials Use By Doctors USD Million (2019-2024)
  • Table 184. China Total Hip Replacement, by Approach Type USD Million (2019-2024)
  • Table 185. China Total Hip Replacement, by Treat Conditions USD Million (2019-2024)
  • Table 186. Japan Total Hip Replacement, by Application USD Million (2019-2024)
  • Table 187. Japan Total Hip Replacement, by Materials Use By Doctors USD Million (2019-2024)
  • Table 188. Japan Total Hip Replacement, by Approach Type USD Million (2019-2024)
  • Table 189. Japan Total Hip Replacement, by Treat Conditions USD Million (2019-2024)
  • Table 190. India Total Hip Replacement, by Application USD Million (2019-2024)
  • Table 191. India Total Hip Replacement, by Materials Use By Doctors USD Million (2019-2024)
  • Table 192. India Total Hip Replacement, by Approach Type USD Million (2019-2024)
  • Table 193. India Total Hip Replacement, by Treat Conditions USD Million (2019-2024)
  • Table 194. South Korea Total Hip Replacement, by Application USD Million (2019-2024)
  • Table 195. South Korea Total Hip Replacement, by Materials Use By Doctors USD Million (2019-2024)
  • Table 196. South Korea Total Hip Replacement, by Approach Type USD Million (2019-2024)
  • Table 197. South Korea Total Hip Replacement, by Treat Conditions USD Million (2019-2024)
  • Table 198. Taiwan Total Hip Replacement, by Application USD Million (2019-2024)
  • Table 199. Taiwan Total Hip Replacement, by Materials Use By Doctors USD Million (2019-2024)
  • Table 200. Taiwan Total Hip Replacement, by Approach Type USD Million (2019-2024)
  • Table 201. Taiwan Total Hip Replacement, by Treat Conditions USD Million (2019-2024)
  • Table 202. Australia Total Hip Replacement, by Application USD Million (2019-2024)
  • Table 203. Australia Total Hip Replacement, by Materials Use By Doctors USD Million (2019-2024)
  • Table 204. Australia Total Hip Replacement, by Approach Type USD Million (2019-2024)
  • Table 205. Australia Total Hip Replacement, by Treat Conditions USD Million (2019-2024)
  • Table 206. Rest of Asia-Pacific Total Hip Replacement, by Application USD Million (2019-2024)
  • Table 207. Rest of Asia-Pacific Total Hip Replacement, by Materials Use By Doctors USD Million (2019-2024)
  • Table 208. Rest of Asia-Pacific Total Hip Replacement, by Approach Type USD Million (2019-2024)
  • Table 209. Rest of Asia-Pacific Total Hip Replacement, by Treat Conditions USD Million (2019-2024)
  • Table 210. Europe Total Hip Replacement, by Country USD Million (2019-2024)
  • Table 211. Europe Total Hip Replacement, by Application USD Million (2019-2024)
  • Table 212. Europe Total Hip Replacement, by Materials Use By Doctors USD Million (2019-2024)
  • Table 213. Europe Total Hip Replacement, by Approach Type USD Million (2019-2024)
  • Table 214. Europe Total Hip Replacement, by Treat Conditions USD Million (2019-2024)
  • Table 215. Germany Total Hip Replacement, by Application USD Million (2019-2024)
  • Table 216. Germany Total Hip Replacement, by Materials Use By Doctors USD Million (2019-2024)
  • Table 217. Germany Total Hip Replacement, by Approach Type USD Million (2019-2024)
  • Table 218. Germany Total Hip Replacement, by Treat Conditions USD Million (2019-2024)
  • Table 219. France Total Hip Replacement, by Application USD Million (2019-2024)
  • Table 220. France Total Hip Replacement, by Materials Use By Doctors USD Million (2019-2024)
  • Table 221. France Total Hip Replacement, by Approach Type USD Million (2019-2024)
  • Table 222. France Total Hip Replacement, by Treat Conditions USD Million (2019-2024)
  • Table 223. Italy Total Hip Replacement, by Application USD Million (2019-2024)
  • Table 224. Italy Total Hip Replacement, by Materials Use By Doctors USD Million (2019-2024)
  • Table 225. Italy Total Hip Replacement, by Approach Type USD Million (2019-2024)
  • Table 226. Italy Total Hip Replacement, by Treat Conditions USD Million (2019-2024)
  • Table 227. United Kingdom Total Hip Replacement, by Application USD Million (2019-2024)
  • Table 228. United Kingdom Total Hip Replacement, by Materials Use By Doctors USD Million (2019-2024)
  • Table 229. United Kingdom Total Hip Replacement, by Approach Type USD Million (2019-2024)
  • Table 230. United Kingdom Total Hip Replacement, by Treat Conditions USD Million (2019-2024)
  • Table 231. Netherlands Total Hip Replacement, by Application USD Million (2019-2024)
  • Table 232. Netherlands Total Hip Replacement, by Materials Use By Doctors USD Million (2019-2024)
  • Table 233. Netherlands Total Hip Replacement, by Approach Type USD Million (2019-2024)
  • Table 234. Netherlands Total Hip Replacement, by Treat Conditions USD Million (2019-2024)
  • Table 235. Rest of Europe Total Hip Replacement, by Application USD Million (2019-2024)
  • Table 236. Rest of Europe Total Hip Replacement, by Materials Use By Doctors USD Million (2019-2024)
  • Table 237. Rest of Europe Total Hip Replacement, by Approach Type USD Million (2019-2024)
  • Table 238. Rest of Europe Total Hip Replacement, by Treat Conditions USD Million (2019-2024)
  • Table 239. MEA Total Hip Replacement, by Country USD Million (2019-2024)
  • Table 240. MEA Total Hip Replacement, by Application USD Million (2019-2024)
  • Table 241. MEA Total Hip Replacement, by Materials Use By Doctors USD Million (2019-2024)
  • Table 242. MEA Total Hip Replacement, by Approach Type USD Million (2019-2024)
  • Table 243. MEA Total Hip Replacement, by Treat Conditions USD Million (2019-2024)
  • Table 244. Middle East Total Hip Replacement, by Application USD Million (2019-2024)
  • Table 245. Middle East Total Hip Replacement, by Materials Use By Doctors USD Million (2019-2024)
  • Table 246. Middle East Total Hip Replacement, by Approach Type USD Million (2019-2024)
  • Table 247. Middle East Total Hip Replacement, by Treat Conditions USD Million (2019-2024)
  • Table 248. Africa Total Hip Replacement, by Application USD Million (2019-2024)
  • Table 249. Africa Total Hip Replacement, by Materials Use By Doctors USD Million (2019-2024)
  • Table 250. Africa Total Hip Replacement, by Approach Type USD Million (2019-2024)
  • Table 251. Africa Total Hip Replacement, by Treat Conditions USD Million (2019-2024)
  • Table 252. North America Total Hip Replacement, by Country USD Million (2019-2024)
  • Table 253. North America Total Hip Replacement, by Application USD Million (2019-2024)
  • Table 254. North America Total Hip Replacement, by Materials Use By Doctors USD Million (2019-2024)
  • Table 255. North America Total Hip Replacement, by Approach Type USD Million (2019-2024)
  • Table 256. North America Total Hip Replacement, by Treat Conditions USD Million (2019-2024)
  • Table 257. United States Total Hip Replacement, by Application USD Million (2019-2024)
  • Table 258. United States Total Hip Replacement, by Materials Use By Doctors USD Million (2019-2024)
  • Table 259. United States Total Hip Replacement, by Approach Type USD Million (2019-2024)
  • Table 260. United States Total Hip Replacement, by Treat Conditions USD Million (2019-2024)
  • Table 261. Canada Total Hip Replacement, by Application USD Million (2019-2024)
  • Table 262. Canada Total Hip Replacement, by Materials Use By Doctors USD Million (2019-2024)
  • Table 263. Canada Total Hip Replacement, by Approach Type USD Million (2019-2024)
  • Table 264. Canada Total Hip Replacement, by Treat Conditions USD Million (2019-2024)
  • Table 265. Mexico Total Hip Replacement, by Application USD Million (2019-2024)
  • Table 266. Mexico Total Hip Replacement, by Materials Use By Doctors USD Million (2019-2024)
  • Table 267. Mexico Total Hip Replacement, by Approach Type USD Million (2019-2024)
  • Table 268. Mexico Total Hip Replacement, by Treat Conditions USD Million (2019-2024)
  • Table 269. Research Programs/Design for This Report
  • Table 270. Key Data Information from Secondary Sources
  • Table 271. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Total Hip Replacement: by Application USD Million (2013-2018)
  • Figure 5. Global Total Hip Replacement: by Materials Use By Doctors USD Million (2013-2018)
  • Figure 6. Global Total Hip Replacement: by Approach Type USD Million (2013-2018)
  • Figure 7. Global Total Hip Replacement: by Treat Conditions USD Million (2013-2018)
  • Figure 8. South America Total Hip Replacement Share (%), by Country
  • Figure 9. Asia Pacific Total Hip Replacement Share (%), by Country
  • Figure 10. Europe Total Hip Replacement Share (%), by Country
  • Figure 11. MEA Total Hip Replacement Share (%), by Country
  • Figure 12. North America Total Hip Replacement Share (%), by Country
  • Figure 13. Global Total Hip Replacement share by Players 2018 (%)
  • Figure 14. Global Total Hip Replacement share by Players (Top 3) 2018(%)
  • Figure 15. Global Total Hip Replacement share by Players (Top 5) 2018(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Johnson & Johnson (United States) Revenue, Net Income and Gross profit
  • Figure 18. Johnson & Johnson (United States) Revenue: by Geography 2018
  • Figure 19. Stryker (United States) Revenue, Net Income and Gross profit
  • Figure 20. Stryker (United States) Revenue: by Geography 2018
  • Figure 21. Zimmer Biomet (United States) Revenue, Net Income and Gross profit
  • Figure 22. Zimmer Biomet (United States) Revenue: by Geography 2018
  • Figure 23. Smith & Nephew (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 24. Smith & Nephew (United Kingdom) Revenue: by Geography 2018
  • Figure 25. Wright Medical (United States) Revenue, Net Income and Gross profit
  • Figure 26. Wright Medical (United States) Revenue: by Geography 2018
  • Figure 27. ConforMIS (United States) Revenue, Net Income and Gross profit
  • Figure 28. ConforMIS (United States) Revenue: by Geography 2018
  • Figure 29. Corin (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 30. Corin (United Kingdom) Revenue: by Geography 2018
  • Figure 31. Maxx Orthopedics Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 32. Maxx Orthopedics Inc. (United States) Revenue: by Geography 2018
  • Figure 33. Global Total Hip Replacement: by Application USD Million (2019-2024)
  • Figure 34. Global Total Hip Replacement: by Materials Use By Doctors USD Million (2019-2024)
  • Figure 35. Global Total Hip Replacement: by Approach Type USD Million (2019-2024)
  • Figure 36. Global Total Hip Replacement: by Treat Conditions USD Million (2019-2024)
  • Figure 37. South America Total Hip Replacement Share (%), by Country
  • Figure 38. Asia Pacific Total Hip Replacement Share (%), by Country
  • Figure 39. Europe Total Hip Replacement Share (%), by Country
  • Figure 40. MEA Total Hip Replacement Share (%), by Country
  • Figure 41. North America Total Hip Replacement Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Johnson & Johnson (United States)
  • Stryker (United States)
  • Zimmer Biomet (United States)
  • Smith & Nephew (United Kingdom)
  • Wright Medical (United States)
  • ConforMIS (United States)
  • Corin (United Kingdom)
  • Maxx Orthopedics Inc. (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation